The Mets are saying they won’t consider Steven Matz out of the bullpen, despite Josh Edgin’s injured elbow.
What they aren’t saying is why. This approach leads to numerous questions and maybe a conclusion or two.
MATZ: Why not the pen?
Do they think Edgin’s injury isn’t as worse as initially believed? Even if he’s ready for the season, what about a second lefty?
Are they that sold on Rule 5 pick Sean Gilmartin or Scott Rice, Jack Leathersich and Dario Alvarez? They either have to use Gilmartin or lose him, so he should get the first shot. But what if he’s a bust?
“It’s way too early to say anything about anybody,’’ pitching coach Dan Warthen told reporters Tuesday. “We are looking at lefties, so I don’t know. We have been looking at lefties every year, so I don’t have an evaluation right now.’’
What was their reasoning for letting Dana Eveland go? What about not even considering Phil Coke?
There’s plenty of time left, but I want to go back to Matz. If Warthen said he doesn’t have an evaluation, what harm would it do in trying him out of the pen?
The Mets have been telling us they plan to be competitive this season, but that would be hard to do without a lefty out of the bullpen.
Is Matz that fragile where he can’t work out of the pen for a while? If he’s that fragile, wouldn’t that be something the Mets would want to know?
If Matz is as highly regarded as the Mets believe, then what is the problem? Would a year out of the bullpen damage him that much? Dave Righetti was able to do it.
If they have reason to believe Matz isn’t capable, I will buy that, but they haven’t said so.
A lefty reliever is vital, and if the Mets are as good as they are saying, then why not roll the dice on Matz? It makes me wonder if the Mets don’t think Matz is good enough, or if the Mets aren’t good enough.